Gary Ulness Email & Phone Number

Omaha, Ne, Us

Omaha, Ne, Us

Ne, Ia, Nd, Sd, Mn, Wi, Ks

Nebraska, United States

Arizona & Nevada

Cover AZ & NV with first to market MRD ctDNA diagnostic test, Signatera.

Phoenix, Tucson, Arizona Area

Responsible for Oncology Portfolio in Phoenix, Tucson and southern Arizona area.

Nebraska, Iowa

Responsible for Oncology portfolio in Nebraska and Iowa.

Omaha, Ne

Launch 1st ever Biosimilar approved in the U.S. Represent BioOncology Injectible to Hospitals, Clinics, Pharmacies in Iowa, Nebraska and South Dakota.

Responsible for sales and support of "buy and bill" drug Xofigo for castrate resistant prostate cancer. Responsible for the launch and growth of a new oral Multi-Kinase Inhibitor (Stivarga) for Metastatic Colorectal Cancer.Responsible for maintaing and supporting Multi-Kinase Inhibitor (Nexavar) for HCC and RCC.Frequently conducted in-services to oncology nurses and staff. Cover the entire state of Nebraska.

Responsible for growing market share for a Targeted Oral TKI (Tarceva) for Non-Small Cell Lung Cancer and Pancreatic Cancer as well as the launch and growth of an oral, small molecule, kinase inhibitor (Zelboraf) for Metastatic Melanoma to Medical Oncologist in assigned territory.Covered large geographic areas: Iowa, Nebraska, and South Dakota and parts of MO. Frequently conducted in-services to oncology nurses and staff. Successfully launched Zelboraf in August 2011 to treat ever challenging Melanoma market.

Responsible for growing new market share as well as maintaining existing market share within assigned territory. Responsible for promoting and supporting Glaucoma (Xalatan) and wet-AMD injectable product (Macugen) to targeted Ophthalmologist and Optometrists, Glaucoma Specialists and Retina Specialists.Covered large geographic areas in Iowa, Nebraska, and South Dakota. Implemented sales strategy and sales plan to achieve annual quota.Fostered strong relationships with all physicians and staff.Successfully launched Macugen, the first injectable anti-VEGF inhibitor for the treatment of Wet AMD.

Called on physicians in eastern Nebraska and western Iowa. Represented Knoll Pharmaceutical through a contract organization. Developed relationships with Oral Surgeons and Orthopedic Surgeons to grow acute pain market.Demonstrated use of marketing tools and resources to achieve sales goals.Performance / Awards:Produced the second highest tablet volume for Vicoprofen in the district.Achieved call average every month to target physicians.Developed strong support and growth within assigned geographic area.